Se connecter

Bibliographies thématiques / Mesothelin targeted cancer immunotherapy / Livres

Livres sur le sujet « Mesothelin targeted cancer immunotherapy »

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Mesothelin targeted cancer immunotherapy.

Auteur : Grafiati

Publié le 11 mars 2023

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 30 meilleurs livres pour votre recherche sur le sujet « Mesothelin targeted cancer immunotherapy ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les livres sur diverses disciplines et organisez correctement votre bibliographie.

1

Yan, Cui, Li Shulin et SpringerLink (Online service), dir. Targeted Cancer Immune Therapy. New York, NY : Springer-Verlag New York, 2009.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

N, Syrigos Konstantinos, et Harrington Kevin J. 1958-, dir. Targeted therapy for cancer. Oxford : Oxford University Press, 2003.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

Anderson, Kenneth C., Razelle Kurzrock et Apostolia-Maria Tsimberidou. Targeted therapy in translational cancer research. Hoboken, New Jersey : John Wiley & Sons, Inc., 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Alharbi, Yousef, Manish S. Patankar et Rebecca J. Whelan. Antibody-Based Therapy for Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0006.

Texte intégral

Résumé :

With their role in connecting disease-associated antigens to the cellular immune response, antibodies hold considerable promise as therapeutic agents. This chapter discusses three classes of therapeutic antibodies that have been developed for use in ovarian cancer therapy. The first includes antibodies selected against tumor-associated antigens such as MUC16/CA125, mesothelin, epithelial cell adhesion molecule, and folate receptor α‎. Antibodies in the second class target proteins such as CTLA-4 and PD1 that act as immune response checkpoint receptors. The third class of antibodies target secreted factors that promote tumor growth: targets in this class include vascular endothelial growth factor, cytokines, and chemokines. The development of each of these is described. The chapter also discusses the complications presented by soluble antigens, which serve to limit the applicability of antigens (such as MUC16/CA125) that are both cell-surface associated and circulating and the prospects for the combination of antibody-based immunotherapy and chemotherapy.

Styles APA, Harvard, Vancouver, ISO, etc.

5

Williams, William Valentine, Karen Anderson, David B. Weiner et Cara Haymaker, dir. Targeted Immunotherapy for Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-074-9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Li, Shulin, Yan Cui et Joseph Lustgarten. Targeted Cancer Immune Therapy. Springer New York, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2019.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Olle, David A. Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2022.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Olle, David A. Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2022.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Karp, Daniel D., Gerald S. Falchook MD MS et Joann Lim. Handbook of Targeted Cancer Therapy and Immunotherapy. LWW, 2018.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

11

Karp, Daniel D., Joann Lim et Gerald S. Falchook. Handbook of Targeted Cancer Therapy and Immunotherapy. Lippincott Williams & Wilkins, 2022.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

12

Olle, David A. Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2022.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

Handbook of Targeted Cancer Therapy and Immunotherapy : Gastrointestinal Cancer. Lippincott Williams & Wilkins, 2021.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

14

Targeted therapies in oncology. New York : Informa Healthcare, 2007.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

15

Resistance to Immunotherapeutic Antibodies in Cancer Resistance to Targeted AntiCancer Therapeutics. Springer-Verlag New York Inc., 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

16

Markman, Maurie, Kenneth C. Anderson, Razelle Kurzrock, Apostolia-Maria Tsimberidou et Robert C. Bast. Targeted Therapy in Translational Cancer Research. Wiley & Sons, Incorporated, John, 2015.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

17

Markman, Maurie, Kenneth C. Anderson, Razelle Kurzrock, Bast Robert C. Jr et Apostolia-Maria Tsimberidou. Targeted Therapy in Translational Cancer Research. Wiley & Sons, Incorporated, John, 2015.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

18

Markman, Maurie, Kenneth C. Anderson, Razelle Kurzrock, Bast Robert C. Jr et Apostolia-Maria Tsimberidou. Targeted Therapy in Translational Cancer Research. Wiley & Sons, Limited, John, 2015.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

19

Targeted Therapies in Oncology. CRC Press, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

Giaccone, Giuseppe, et Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2019.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

21

Giaccone, Giuseppe, et Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

22

Giaccone, Giuseppe, et Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2007.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

23

Giaccone, Giuseppe, et Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

24

(Editor), Giuseppe Giaccone, et Jean-Charles Soria (Editor), dir. Targeted Therapies in Oncology. Informa Healthcare, 2007.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

25

Jiang, Tao, Zhu Bo, Shengxiang Ren et Tetsuya Mitsudomi, dir. Multi-dimensional Biomarkers and Resistance Mechanism of Targeted Therapy and Immunotherapy in Lung Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-265-3.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

26

Melanoma Emerging Cancer Therapeutics. Demos Medical Publishing, 2012.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

27

Targeted Radionuclide Tumor Therapy Biological Aspects. Springer, 2008.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

28

Aljabali, Alaa A., et Kaushik Pal, dir. Bionanotechnology : Next-Generation Therapeutic Tools. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/97898150512781220101.

Texte intégral

Résumé :

Nanoscale technologies are crucial for the characterization and fabrication of biomaterials that are useful in targeted drug delivery systems. New materials enable the delivery of therapeutic agents to specific tissues and cells in order to treat a range of diseases. Bionanotechnology: Next-Generation Therapeutic Tools provides a quick overview of the use of nanomaterials in modern drug delivery and targeted drug therapy systems. The book starts with an overview of nanomaterial toxicity with subsequent chapters detailing their applications in nanomedicine. Concepts such as immunotherapy, cancer theranostics, molecular imaging, aptamers and viral nanoparticles are highlighted in specific chapters. The simplified presentation along with scientific references makes this book ideal for pharmacology and biomedical engineering scholars and life science readers.

Styles APA, Harvard, Vancouver, ISO, etc.

29

Fancourt, Daisy. Fact file 7 : Oncology. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198792079.003.0020.

Texte intégral

Résumé :

Oncology is a branch of medicine focusing on the prevention, diagnosis, and treatment of cancers; one of the leading causes of death in the world. Early records of cancer have been found in fossils from mummies in ancient Egypt and are discussed in some ancient manuscripts, attesting to the long history of the condition. Oncology teams often encompass medical oncologists (who can specialize in chemotherapy, immunotherapy, hormonal therapy, and targeted therapy), surgical oncologists, radiation oncologists, and doctors with specialities in the organs affected....

Styles APA, Harvard, Vancouver, ISO, etc.

30

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff et Madhumita Bhattacharyya. Gynaecological cancers. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0020_update_001.

Texte intégral

Résumé :

Genitourinary cancers examines the malignancies arising in the kidney, ureter, bladder, prostate, testis, and penis. Renal cancer has high propensity for systemic spread, largely mediated by overexpression of vascular endothelial growth factor (VEGF). Treatments include surgery, immunotherapy, and targeted therapy. Wilms tumour, a childhood malignancy of the kidney, warrants specialist paediatric oncology management to provide expertise in its unique pathology, staging, and treatment, often with surgery and chemotherapy. Cancer of the bladder and ureters, another tobacco related cancer, may present as either superficial or invasive disease. The former is managed by transurethral resection and intravesical therapy. The latter may require radical surgery, preoperative chemotherapy, or radiotherapy. Prostate cancer, the commonest male cancer, is an androgen dependent malignancy. It has attracted controversy with regards to PSA screening, and potential over treatment with radical prostatectomy. Division into low, intermediate, and high risk disease according to tumour grade, stage, and PSA helps in deciding best treatment, antiandrogen therapy for metastatic disease, radiotherapy and adjuvant hormone therapy for locally advanced disease, either surgery or radiotherapy for early intermediate risk disease, and active monitoring for low risk cases. Testicular cancer divides according to pathology into seminoma, nonseminomatous germ cell tumours (NSGCT), and mixed tumours, the latter two frequently producing tumour markers, alpha-fetoprotein (AFP) and/or human chorionic gonadotrophin (HCG). Stage I disease is managed by inguinal orchidectomy and surveillance or adjuvant chemotherapy. More advanced disease is managed by chemotherapy, with high probability of cure in the majority. Penile cancer, often HPV related, can be excised when it presents early, but delay in presentation may lead to regional and systemic spread with poor prognosis.

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!